Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd

Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd

sales@dingminpharma.com

86-311-67591193

Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd

All
  • All
  • Title
Language

Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd

 [Hebei,China]

Business Type:Manufacturer , Trade Company , Distributor/Wholesaler

Main Markets: Americas , Asia , East Europe , Europe , North Europe , Oceania , Other Markets , West Europe , Worldwide , Africa , Caribbean , Middle East

Exporter:81% - 90%

Certs:ISO9001, CCC, FDA, MSDS, FCC, REACH, RoHS

Home> Industry Information

Industry Information

Update December 20, 2019
Azazacitidine was first marketed, only 5.6% lower than the original research
First imitation On September 29, 2019, Zhengda Tianqing Pharmaceutical Group first approved azacitidine for injection, with the trade name: Weishou. It was issued three times before and was finally...
Read more >
Update September 03, 2019
Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis
Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis FOSTER CITY, Calif.--Jul. 19, 2019--Gilead Sciences, Inc. (NASDAQ: GILD) announced today that it has licensed...
Read more >
Update February 21, 2019
Pharmaceutical intermediate manufacture APIs Merchants in China
"Over the past 60 years, the pharmaceutical industry has made remarkable achievements, but as we look ahead at the future, we must also see that China still has a long way to go before it becomes a...
Read more >

Most Popular

Azazacitidine was first marketed, only 5.6% lower than the original research
Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis
Pharmaceutical intermediate manufacture APIs Merchants in China

lastest New

Sun Pharma, Dr Reddy's, Aurobindo recall products in the US market
Researchers demonstrate new method to treat Crohn's disease
China prepares large-scale rollout of Covid-19 vaccines
Moderna: Covid vaccine shows nearly 95% protection

Related Products

Enzalutamide Intermediates CAS No.143782-23-4
Enzalutamide Intermediates CAS No.143782-23-4
Diroximel Fumarate CAS NO.1577222-14-0
Diroximel Fumarate CAS NO.1577222-14-0
CAS NO.162359-56-0 Fingolimod hydrochloride
CAS NO.162359-56-0 Fingolimod hydrochloride

Send Inquiry

Home> Industry Information
Related Products List
API Raw Material Pharma Pharmaceutical Intermediates Active Pharmaceutical Ingredients Agrochemical Intermediates Fine Chemicals

Home

Product

Phone

About Us

Inquiry
Please Leave Us A Message

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Upload Attachment
Send